Aflac Incorporated (NYSE:AFL) Shares Sold by Bison Wealth LLC

Bison Wealth LLC decreased its holdings in Aflac Incorporated (NYSE:AFL) by 3.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,189 shares of the financial services provider’s stock after selling 134 shares during the quarter. Bison Wealth LLC’s holdings in Aflac were worth $346,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Baystate Wealth Management LLC grew its stake in Aflac by 24.1% during the 3rd quarter. Baystate Wealth Management LLC now owns 675 shares of the financial services provider’s stock worth $52,000 after purchasing an additional 131 shares in the last quarter. Dominguez Wealth Management Solutions Inc. grew its holdings in Aflac by 0.5% during the 3rd quarter. Dominguez Wealth Management Solutions Inc. now owns 24,969 shares of the financial services provider’s stock worth $1,916,000 after acquiring an additional 132 shares in the last quarter. Brighton Jones LLC increased its position in shares of Aflac by 2.3% in the 3rd quarter. Brighton Jones LLC now owns 6,156 shares of the financial services provider’s stock valued at $472,000 after purchasing an additional 136 shares during the last quarter. MV Capital Management Inc. raised its holdings in shares of Aflac by 3.7% in the 3rd quarter. MV Capital Management Inc. now owns 3,779 shares of the financial services provider’s stock valued at $290,000 after purchasing an additional 136 shares in the last quarter. Finally, Simon Quick Advisors LLC lifted its position in shares of Aflac by 4.9% during the 4th quarter. Simon Quick Advisors LLC now owns 2,950 shares of the financial services provider’s stock worth $243,000 after purchasing an additional 139 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Evercore ISI cut Aflac from an “in-line” rating to an “underperform” rating and upped their price objective for the stock from $76.00 to $78.00 in a research report on Thursday, January 4th. The Goldman Sachs Group upped their price target on Aflac from $61.00 to $75.00 and gave the company a “sell” rating in a report on Tuesday, January 9th. Raymond James raised their price objective on shares of Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. UBS Group upped their target price on shares of Aflac from $80.00 to $84.00 and gave the company a “neutral” rating in a report on Wednesday, January 10th. Finally, Morgan Stanley increased their target price on shares of Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a research report on Monday. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $82.15.

Aflac Trading Up 0.2 %

Shares of Aflac stock opened at $80.42 on Wednesday. The firm has a market cap of $46.27 billion, a price-to-earnings ratio of 10.38, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91. Aflac Incorporated has a 52-week low of $64.10 and a 52-week high of $86.26. The company’s 50-day simple moving average is $82.03 and its 200-day simple moving average is $81.47. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.33.

Aflac (NYSE:AFL) last released its earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.47 by ($0.22). The business had revenue of $3.78 billion for the quarter, compared to analyst estimates of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same quarter in the previous year, the firm posted $1.29 EPS. As a group, equities research analysts anticipate that Aflac Incorporated will post 6.41 earnings per share for the current year.

Insiders Place Their Bets

In related news, SVP Albert Riggieri sold 8,000 shares of the firm’s stock in a transaction dated Thursday, March 14th. The shares were sold at an average price of $83.34, for a total value of $666,720.00. Following the completion of the sale, the senior vice president now owns 32,825 shares in the company, valued at $2,735,635.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Masatoshi Koide sold 30,493 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the transaction, the director now owns 86,090 shares of the company’s stock, valued at $6,879,451.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Albert Riggieri sold 8,000 shares of the stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $83.34, for a total value of $666,720.00. Following the transaction, the senior vice president now directly owns 32,825 shares in the company, valued at approximately $2,735,635.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 46,493 shares of company stock worth $3,765,706. 0.80% of the stock is owned by corporate insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.